Section 20-2A-80 – Tax on Retail Sales of Medical Cannabis; Annual Medical Cannabis Privilege Tax.
Section 20-2A-80 Tax on retail sales of medical cannabis; annual medical cannabis privilege tax. (a) Commencing January 1, 2022, there is levied, in addition to all other taxes of every kind now imposed by law, and shall be collected and remitted in accordance with Article 1, commencing with Section 40-23-1, of Chapter 23 of Title […]
Section 20-2A-54 – Statewide Seed-to-Sale Tracking System.
Section 20-2A-54 Statewide seed-to-sale tracking system. (a) In order to ensure that all medical cannabis sold in the state maintains product quality to protect the health and welfare of state residents, the commission shall establish a statewide seed-to-sale tracking system for use as an integrated cannabis and medical cannabis tracking, inventory, and verification system. The […]
Section 20-2A-100 – Creation, Composition; Board of Directors; Purposes; Annual Report; Medical Cannabis Research Fund.
Section 20-2A-100 Creation, composition; board of directors; purposes; annual report; Medical Cannabis Research Fund. (a) As used in this section, cannabis, medical cannabis, and use of medical cannabis shall have the same meanings as defined in Section 20-2A-3. (b) There is established the Consortium for Medical Cannabis Research for the purpose of awarding grants to […]
Section 20-2A-55 – License Application Procedures.
Section 20-2A-55 License application procedures. (a) Beginning September 1, 2022, a person may apply to the commission for a license for an integrated facility or for a license in one of the following independent categories: Cultivator, processor, secure transporter, state testing laboratory, or dispensary. The application shall be made under oath on a form provided […]
Section 20-3-1 – Short Title.
Section 20-3-1 Short title. This chapter shall be known and cited as the “John G. Page, Jr., Act.” (Act 2002-498, p. 1288, §1.)
Section 20-2A-56 – Notice and Comment Period; License Ineligibility; Issuance or Denial; Fee; Expiration and Renewal.
Section 20-2A-56 Notice and comment period; license ineligibility; issuance or denial; fee; expiration and renewal. (a) Before issuing any license under this article, the commission shall provide notice and a 30-day period during which members of the public may submit written comments regarding an applicant. The commission shall consider all comments received during the 30-day […]
Section 20-3-2 – Definitions.
Section 20-3-2 Definitions. As used in this chapter, the following terms shall have the following meanings: (1) ASSISTED LIVING FACILITY. An institution or facility licensed as an assisted living facility under regulations of the State Board of Health. (2) CHARITABLE CLINIC. The term includes an established free medical clinic as defined in subdivision (1) of […]
Section 20-2A-57 – Suspension, Revocation, etc., of License.
Section 20-2A-57 Suspension, revocation, etc., of license. (a) If any of the following occurs, the commission may deny, suspend, revoke, or restrict a license: (1) An applicant or licensee fails to comply with this article or rules. (2) A licensee no longer meets the eligibility requirements for a license under this article. (3) An applicant […]
Section 20-3-3 – Transfer of Legend Drugs to Charitable Clinic.
Section 20-3-3 Transfer of legend drugs to charitable clinic. (a)(1) Legend drugs, except controlled substances, dispensed to a patient in a hospital, nursing facility, assisted living facility, or specialty care assisted living facility may be donated and transferred pursuant to this section to a charitable clinic to be used by charitable patients free of charge […]
Section 20-2A-58 – Exclusivity of License; Transfer Request.
Section 20-2A-58 Exclusivity of license; transfer request. (a) Each license is exclusive to the licensee. A license, and any interest in or rights under a license, and any ownership interest or other beneficial interest in a licensed entity, may not be sold, transferred, assigned, conveyed, or otherwise disposed of in any manner, in whole or […]